Bosentan PK in PAH Patients Concentrations after 62.5 mg Single Dose

8/15/01


Click here to start


Table of Contents

Bosentan PK in PAH Patients Concentrations after 62.5 mg Single Dose

Interaction with Ketoconazole Bosentan Trough Plasma Levels

Choice of Doses for Clinical Trials

Long-term Exposure to Bosentan

Change in WBC and Platelets 8 Placebo-controlled Studies

Risk of Hospitalization AC-052-352

Patient Registry (To Be Discussed with the FDA)

Author: Chris and Marty